| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 45 |
| 1 | ATEZOLIZUMAB | 38 |
| 2 | ADALIMUMAB | 25 |
| 3 | ASPIRIN | 17 |
| 4 | ASPIRIN 325 MG | 17 |
| 5 | ASPIRIN 81 MG | 17 |
| 6 | METHOTREXATE | 16 |
| 7 | METHOTREXATE SODIUM | 16 |
| 8 | RIVAROXABAN | 15 |
| 9 | ERGOCALCIFEROL | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZAFIRLUKAST | 1 | 0.0011 |
| 1 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0011 |
| 2 | NITISINONE | 1 | 0.0010 |
| 3 | SILODOSIN | 4 | 0.0010 |
| 4 | ATEZOLIZUMAB | 38 | 0.0010 |
| 5 | TREMELIMUMAB | 4 | 0.0009 |
| 6 | ADEFOVIR DIPIVOXIL | 1 | 0.0008 |
| 7 | ETHIODIZED OIL | 1 | 0.0008 |
| 8 | ZIV-AFLIBERCEPT | 1 | 0.0008 |
| 9 | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 38 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 4 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 48 | 0.0003 |
| 6 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 8 | 0.0002 |